Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.42
+0.44501.59%
Volume:14.22M
Turnover:402.62M
Market Cap:161.56B
PE:37.39
High:28.56
Open:27.94
Low:27.84
Close:27.97
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.64
T/O Rate:0.25%
Dividend:1.72
Dividend Rate:6.06%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.90
PE(LYR):20.83

Loading ...

Aug 04, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2026

Major Issues Report

Form 8-K - Current report
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Jun 18, 2026

Major Issues Report

Form 8-K - Current report
Jun 16, 2026

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
Jun 16, 2026

Employee Stock Ownership

Form 11-K - Annual report of employee stock purchase, savings and similar plans
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 05, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
May 01, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 27, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 03, 2026

Major Issues Report

Form 8-K - Current report
Dec 16, 2025

Major Issues Report

Form 8-K - Current report
Nov 21, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2025

Major Issues Report

Form 8-K - Current report